Source: Abstracts. Conference titles: European Atherosclerosis Society Congress/EAS. Unidades: IB, FM, FCF
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Lipid core nanoparticle associated with methotrexate improved left ventricular cardiomyopathy in mice with marfan syndrome. 2022, Anais.. Genebra: EAS, 2022. Disponível em: https://cslide.ctimeetingtech.com/global_storage/media/content/eas22/EAS_ePoster_Viewing_list_May_22.pdf. Acesso em: 20 ago. 2024.APA
Guido, M. C., Lopes, N. de M., Carvalho, P. O. de, Silva, A. de O., Jensen, L., Pereira, L. da V., et al. (2022). Lipid core nanoparticle associated with methotrexate improved left ventricular cardiomyopathy in mice with marfan syndrome. In Abstracts. Genebra: EAS. Recuperado de https://cslide.ctimeetingtech.com/global_storage/media/content/eas22/EAS_ePoster_Viewing_list_May_22.pdfNLM
Guido MC, Lopes N de M, Carvalho PO de, Silva A de O, Jensen L, Pereira L da V, Dias RR, Laurindo FRM, Maranhão RC. Lipid core nanoparticle associated with methotrexate improved left ventricular cardiomyopathy in mice with marfan syndrome [Internet]. Abstracts. 2022 ;[citado 2024 ago. 20 ] Available from: https://cslide.ctimeetingtech.com/global_storage/media/content/eas22/EAS_ePoster_Viewing_list_May_22.pdfVancouver
Guido MC, Lopes N de M, Carvalho PO de, Silva A de O, Jensen L, Pereira L da V, Dias RR, Laurindo FRM, Maranhão RC. Lipid core nanoparticle associated with methotrexate improved left ventricular cardiomyopathy in mice with marfan syndrome [Internet]. Abstracts. 2022 ;[citado 2024 ago. 20 ] Available from: https://cslide.ctimeetingtech.com/global_storage/media/content/eas22/EAS_ePoster_Viewing_list_May_22.pdf